PDS Biotechnology secures up to $22.55M PIPE financing
PDS Biotechnology Corp. secured a Nant Capital-led PIPE totaling up to $22.55M, with an initial close of about $11.55M and an $11M milestone tied to FDA Phase 3 protocol filing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.